欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
目的评价我院舒血宁注射液临床应用的合理性及安全性。方法跟踪我院212例使用舒血宁注射液的门诊患者（男77名，女135名）的使用情况，填写研究调查表。调查表项目包括年龄、性别、主要诊断、症状、用药剂量及疗程、药品不良反应发生的时间、对患者原患疾病的影响及转归。数据经过了统计分析。结果患者平均年龄（59．8±12．8）岁．使用舒血宁注射液的平均剂量为20mL。疗程平均为（7．5±3．2）d，每日通过静脉滴注给药1次。有13例患者出现怀疑与舒血宁注射液相关的不良反应。总不良反应发生率为5．66％。结论我院舒血宁注射液使用较合理，按说明书推荐方法使用较安全。
英文摘要：
OBJECTIVE To investigate the rationality and safety of Shuxuening injection used in our hospital. METHODS Two hundred and twelve outpatients （77 males, 135 females） were selected. Survey forms designed for this research were filled in with i- tems including age, sex, clinical diagnosis, symptom, dosage, course of treatment, adverse reactions due to the the injection and out-come. Data were analyzed statistically. RESULTS For the 212 cases with an average age of （59. 8±12.8 ） yeas, the average dose of Shuxuening injection was 20 mL, given once daily by intravenous infusion; the duration of therapy was （7.5±3.2） d; the rate of adverse reactions was 5.66%. CONCLUSION Shuxuening injection is used rationally in our hospital, and it is generally safe when used according to the labeling.
同期刊论文项目
同项目期刊论文
期刊信息
位置：